Best known for intermittently producing embarrassing sores on the mouth and genitals, herpes simplex virus (HSV) is more dangerous than most people realize. The virus can blind and even kill people with weak immune systems, such as newborns, elderly people, and AIDS patients.
By targeting one of the virus’ enzymes, two pharmaceutical companies have now independently identified a new class of drugs that stop HSV from replicating.
Log in
Subscribers, enter your e-mail address for full access to the Science News archives and digital editions.